Tom Wilemon Archive — Page 10 of 39
-
October 12, 2023
Symposium for patients, caregivers and family members offers important information on stomach cancer, Nov. 4
A Vanderbilt symposium on Nov. 4 offers detailed information for patients, caregivers and family members about stomach cancer. -
October 5, 2023
Study validates pyrvinium as treatment to prevent stomach cancer
A Vanderbilt study found that a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer. -
October 4, 2023
Vulnerability found in immunotherapy-resistant triple-negative breast cancer
Vanderbilt researchers have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer. -
September 12, 2023
Study finds new genetic susceptibilities for colon cancer
Vanderbilt researchers at have found new genes that put people at higher risk for colon cancer and rectal cancer. -
September 1, 2023
Foundation funds research to block drug resistance in cancer treatment
The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance. -
August 10, 2023
New leaders named to Vanderbilt-Ingram research programs
Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs.